Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis

por Li, Kang-Shuai, Guo, Sen, Chen, Yu-Xin, Zhang, Zong-Li
Publicado 2022

The distal classification and management of choledochal cyst in adults: Based on the relation between cyst and pancreatic duct

por Liu, Yanfeng, Sun, Jingxian, Guo, Sen, Liu, Zengli, Zhu, Min, Zhang, Zong-li
Publicado 2017

Downregulation of EVI1 Expression Inhibits Cell Proliferation and Induces Apoptosis in Hilar Cholangiocarcinoma via the PTEN/AKT Signalling Pathway

por Zhang, Xiao-ming, Liu, Zeng-li, Qiu, Bo, XU, Yun-fei, Pan, Chang, Zhang, Zong-li
Publicado 2020

High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis

por Zhang, Qiang-Bo, Jia, Qing-an, Wang, Hong, Hu, Chun-Xiao, Sun, Dong, Jiang, Run-De, Zhang, Zong-Li
Publicado 2016

SMAD4 regulates the progression of cholangiocarcinoma by modulating the expression of STING1

por Shi, An‐da, Zhao, Li‐ming, Sheng, Guo‐li, Zhang, Ge‐ning, Tang, Yong‐chang, Li, Kang‐shuai, Zhang, Zong‐li
Publicado 2023

Advances in molecular and cell therapy for immunotherapy of cholangiocarcinoma

por Zhao, Li-ming, Shi, An-da, Yang, Yan, Liu, Zeng-li, Hu, Xiao-Qiang, Shu, Li-Zhuang, Tang, Yong-chang, Zhang, Zong-li
Publicado 2023

BRF2 is mediated by microRNA-409-3p and promotes invasion and metastasis of HCC through the Wnt/β-catenin pathway

por Chang, Jian-Hua, Xu, Bo-Wen, Shen, Di, Zhao, Wei, Wang, Yue, Liu, Jia-liang, Meng, Guang-Xiao, Li, Guang-Zhen, Zhang, Zong-Li
Publicado 2023

Cholecystectomy is associated with higher risk of early recurrence and poorer survival after curative resection for early stage hepatocellular carcinoma

por Li, Tao, Wang, Shu-Kang, Zhi, Xu-Ting, Zhou, Jian, Dong, Zhao-Ru, Zhang, Zong-Li, Sun, Hui-Chuan, Ye, Qing-Hai, Fan, Jia
Publicado 2016

Sprouty2 suppresses progression and correlates to favourable prognosis of intrahepatic cholangiocarcinoma via antagonizing FGFR2 signalling

por Xu, Yun‐Fei, Liu, Hong‐Da, Liu, Zeng‐Li, Pan, Chang, Yang, Xiao‐Qing, Ning, Shang‐Lei, Zhang, Zong‐Li, Guo, Sen, Yu, Jin‐Ming
Publicado 2018

Decreased expression of serum semaphorin 3B is associated with poor prognosis of patients with hepatocellular carcinoma

por Li, Guang-Zhen, Shen, Di, Li, Guang-Hong, Wei, Meng, Zheng, Li-Jie, Liu, Zeng-Li, Sun, Rong-Qi, Zhou, Shao-Jun, Zhang, Zong-Li, Gao, Yan-Chao
Publicado 2021

BARMR1-mediated sorafenib resistance is derived through stem-like property acquisition by activating integrin-FAK signaling pathways

por Guo, Xing Rong, Shan, Meng Ye, Huang, Yu, Zhang, Zong Li, Yuan, Yue, Dai, Long Jun, Wang, Jue, Zhou, Xue Peng, Ji, Fu Yun, Tang, Jun Ming, Meng, Zhong Ji, Ruan, Xu Zhi
Publicado 2020

Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers

por Li, Yun-cheng, Li, Kang-shuai, Liu, Zeng-li, Tang, Yong-chang, Hu, Xiao-Qiang, Li, Xing-yong, Shi, An-da, Zhao, Li-ming, Shu, Li-Zhuang, Lian, Shuo, Yan, Zhang-di, Huang, Shao-hui, Sheng, Guo-li, Song, Yan, Liu, Yun-jia, Huan, Fan, Zhang, Ming-hui, Zhang, Zong-li
Publicado 2022